1
|
Yidilisi A, Chen D, Zhang Y, Pu J, Niu T, Hu Y, Fang J, Gong Q, Zheng Y, Huang J, Xiang J, Wang Y, Wang J, Jiang J. Coronary Angiography-Derived Index of Microcirculatory Resistance Predicts Outcome in Patients With ST-Segment-Elevation Myocardial Infarction. Circ Cardiovasc Interv 2024:e013899. [PMID: 38660822 DOI: 10.1161/circinterventions.123.013899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/26/2024]
Affiliation(s)
- Abuduwufuer Yidilisi
- Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
| | - Delong Chen
- Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
| | - Yuxuan Zhang
- Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
| | - Jun Pu
- Department of Cardiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, China (J.P.)
| | - Tiesheng Niu
- Department of Cardiology, Shengjing Hospital of China Medical University (T.N.)
| | - Yumeng Hu
- ArteryFlow Technology Co, Ltd, Hangzhou, China (Y.H., J.X.)
| | - Jiacheng Fang
- Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
| | - Qinyan Gong
- Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
| | - Yiyue Zheng
- Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
| | - Jiniu Huang
- Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
| | - Jianping Xiang
- ArteryFlow Technology Co, Ltd, Hangzhou, China (Y.H., J.X.)
| | - Yaping Wang
- Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
| | - Jian'an Wang
- Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
| | - Jun Jiang
- Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
- Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, China (A.Y., D.C., Y. Zhang, J.F., Q.G., Y. Zheng, J.H., Y.W., J.W., J.J.)
| |
Collapse
|
2
|
Chen D, Yidilisi A, Zhang Y, Fang J, Zheng Y, Gao F, Li W, Zhou H, Chen Y, Lu D, Wang J, Jiang J. Fractional Flow Reserve-Guided Drug-Coated Balloon vs Drug-Eluting Stent for de Novo Non-Small Coronary Lesions. JACC Cardiovasc Interv 2024:S1936-8798(24)00313-3. [PMID: 38385923 DOI: 10.1016/j.jcin.2024.01.276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/29/2023] [Revised: 01/12/2024] [Accepted: 01/16/2024] [Indexed: 02/23/2024]
|
3
|
Aihemaiti A, Fan J, Yidilisi A, Liu X, Wang J. Wearable smartwatch monitoring arrhythmias for patients who at high risk of pacemaker implantation after transcatheter aortic valve replacement. Eur Heart J Digit Health 2023; 4:496-498. [PMID: 38045441 PMCID: PMC10689901 DOI: 10.1093/ehjdh/ztad060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/31/2023] [Revised: 09/27/2023] [Accepted: 10/08/2023] [Indexed: 12/05/2023]
Abstract
Graphical Abstract.
Collapse
Affiliation(s)
- Ailifeire Aihemaiti
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Jiefang Road 88, Hangzhou 310009, China
- Internal Medicine, Zhejiang University School of Medicine, Yuhangtang Road 866, Hangzhou 310058, China
| | - Jiaqi Fan
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Jiefang Road 88, Hangzhou 310009, China
| | - Abuduwufuer Yidilisi
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Jiefang Road 88, Hangzhou 310009, China
- Internal Medicine, Zhejiang University School of Medicine, Yuhangtang Road 866, Hangzhou 310058, China
| | - Xianbao Liu
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Jiefang Road 88, Hangzhou 310009, China
- Internal Medicine, Zhejiang University School of Medicine, Yuhangtang Road 866, Hangzhou 310058, China
| | - Jian’an Wang
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Jiefang Road 88, Hangzhou 310009, China
- Internal Medicine, Zhejiang University School of Medicine, Yuhangtang Road 866, Hangzhou 310058, China
- State Key Laboratory of Transvascular Implantation Devices, Jiefang Road 88, Hangzhou 310009, China
- Cardiovascular Key Laboratory of Zhejiang Province, Jiefang Road 88, Hangzhou 310009, China
| |
Collapse
|
4
|
Liu X, Dai H, Fan J, Zhou D, Zhu G, Yidilisi A, Chen J, Xu Y, Wang L, Wang J. Cerebral ischemic injury after transcatheter aortic valve replacement in patients with pure aortic regurgitation. J Zhejiang Univ Sci B 2023; 24:530-538. [PMID: 37309044 DOI: 10.1631/jzus.b2200444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Considering the surgical risk stratification for patients with severe calcific aortic stenosis (AS), transcatheter aortic valve replacement (TAVR) is a reliable alternative to surgical aortic valve replacement (SAVR) (Fan et al., 2020, 2021; Lee et al., 2021). Despite the favorable clinical benefits of TAVR, stroke remains a dreaded perioperative complication (Auffret et al., 2016; Kapadia et al., 2016; Kleiman et al., 2016; Huded et al., 2019). Ischemic overt stroke, identified in 1.4% to 4.3% of patients in TAVR clinical practice, has been associated with prolonged disability and increased mortality (Auffret et al., 2016; Kapadia et al., 2016; Levi et al., 2022). The prevalence of hyperintensity cerebral ischemic lesions detected by diffusion-weighted magnetic resonance imaging (DW-MRI) was reported to be about 80%, which is associated with impaired neurocognitive function and vascular dementia (Vermeer et al., 2003; Barber et al., 2008; Kahlert et al., 2010).
Collapse
Affiliation(s)
- Xianbao Liu
- Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China
| | - Hanyi Dai
- Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China
| | - Jiaqi Fan
- Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
| | - Dao Zhou
- Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China
| | - Gangjie Zhu
- Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China
| | - Abuduwufuer Yidilisi
- Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China
| | - Jun Chen
- Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China
| | - Yeming Xu
- Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China
| | - Lihan Wang
- Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
| | - Jian'an Wang
- Department of Cardiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China.
| |
Collapse
|
5
|
Liu X, Zhou D, Fan J, Dai H, Zhu G, Chen J, Guo Y, Yidilisi A, Zhu Q, He Y, Wei Y, Liu Q, Qi X, Wang J. Cerebral Ischemic Lesions after Transcatheter Aortic Valve Implantation in Patients with Non-Calcific Aortic Stenosis. J Clin Med 2022; 11:6502. [PMID: 36362730 PMCID: PMC9655232 DOI: 10.3390/jcm11216502] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2022] [Revised: 10/26/2022] [Accepted: 10/31/2022] [Indexed: 04/24/2024] Open
Abstract
Evidence for transcatheter aortic valve implantation (TAVI) is scarce among patients with non-calcific aortic stenosis, and it is not known whether aortic valve calcification is associated with new cerebral ischemic lesions (CILs) that are detected by diffusion-weighted magnetic resonance imaging. So, our study enrolled 328 patients who underwent transfemoral TAVI using a self-expanding valve between December 2016 and June 2021 from the TORCH registry (NCT02803294). A total of 34 patients were finally confirmed as non-calcific AS and the remaining 294 patients were included in the calcific AS group. Incidence of new CILs (70.6% vs. 85.7%, p = 0.022), number of lesions (2.0 vs. 3.0, p = 0.010), and lesions volume (105.0 mm3 vs. 200.0 mm3, p = 0.047) was significantly lower in the non-calcific AS group. However, the maximum and average lesion volumes were comparable between two groups. Non-calcific AS was associated with lower risk for developing new CILs by univariate logistic regression analysis [Odds ratio (OR): 0.040, 95% confident interval (CI): 0.18-0.90, p = 0.026] and multivariate analysis (OR: 0.031, 95% CI: 0.13-0.76, p = 0.010). In summary, non-calcific AS patients had a lower risk of developing new cerebral ischemic infarction after TAVI compared to calcific AS patients. However, new ischemic lesions were still found in over 70% of patients.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | - Jian’an Wang
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou 310009, China
| |
Collapse
|
6
|
Dai H, Zhou D, Fan J, Wang L, Yidilisi A, Zhu G, Jiang J, Li H, Liu X, Wang J. Emergently Alteration of Procedural Strategy During Transcatheter Aortic Valve Replacement to Prevent Coronary Occlusion: A Case Report. Front Cardiovasc Med 2022; 9:931595. [PMID: 35966563 PMCID: PMC9363569 DOI: 10.3389/fcvm.2022.931595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2022] [Accepted: 06/21/2022] [Indexed: 11/13/2022] Open
Abstract
BackgroundCoronary occlusion is an uncommon but fatal complication of transcatheter aortic valve replacement (TAVR) with a poor prognosis.Case PresentationA patient with symptomatic severe bicuspid aortic valve stenosis was admitted to a high-volume center specializing in transfemoral TAVR with self-expanding valves. No anatomical risk factors of coronary occlusion were identified on pre-procedural computed tomography analysis. The patient was scheduled for a transfemoral TAVR with a self-expanding valve. Balloon pre-dilatation prior to prosthesis implantation was routinely used for assessing the supra-annular structure and assessing the risk of coronary occlusion. Immediately after the tubular balloon inflation, fluoroscopy revealed that the right coronary artery was not visible, and the flow in the left coronary artery was reduced. The patient would be at high-risk of coronary occlusion if a long stent self-expanding valve was implanted. Therefore, our heart team decided to suspend the ongoing procedure. A transapical TAVR with a 23 mm J-valve was performed 3 days later. The prosthesis was deployed at a proper position without blocking the coronary ostia and the final fluoroscopy showed normal flow in bilateral coronary arteries with the same filling as preoperatively.DiscussionOur successful case highlights the importance of a comprehensive assessment of coronary risk and a thorough understanding of the TAVR procedure for the heart team. A short-stent prosthesis is feasible for patients at high risk of coronary occlusion. Most importantly TAVR should be called off even if the catheter has been introduced when an extremely high risk of coronary obstruction is identified during the procedure and no solution can be found.
Collapse
Affiliation(s)
- Hanyi Dai
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
| | - Dao Zhou
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
| | - Jiaqi Fan
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
| | - Lihan Wang
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
| | - Abuduwufuer Yidilisi
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
| | - Gangjie Zhu
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
| | - Jubo Jiang
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
| | - Huajun Li
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
| | - Xianbao Liu
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
- *Correspondence: Xianbao Liu,
| | - Jian’an Wang
- Internal Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Department of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
- Jian’an Wang,
| |
Collapse
|
7
|
Zhou D, Yidilisi A, Fan J, Zhang Y, Dai H, Zhu G, Guo Y, He Y, Zhu Q, Lin X, Li H, Jiang J, Ng S, Li C, Ren K, Wang L, Liu X, Wang J. Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis. EUROINTERVENTION 2022; 18:193-202. [PMID: 35044300 PMCID: PMC9912961 DOI: 10.4244/eij-d-21-00734] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
BACKGROUND Transcatheter aortic valve implantation (TAVI) might be a feasible treatment option for more patients with bicuspid aortic valve (BAV) stenosis. However, long-term follow-up data in this population are scarce. AIMS The aim of this study was to evaluate three-year outcomes after TAVI in patients with BAV. METHODS A total of 246 consecutive patients who underwent TAVI at a single centre in China between March 2013 and February 2018 were enrolled in this study. Clinical outcomes, health status and echocardiography were followed and recorded for three years. RESULTS Among 109 (44.3%) BAV patients, 61.5% were Type 0 and 36.7% were Type 1 BAV patients. BAV patients were younger (75 vs 77 years, p=0.041) and had a lower Society of Thoracic Surgeons (STS) score (5.09 vs 6.00, p=0.026) compared to tricuspid aortic valve (TAV) patients. There were no differences in three-year survival rates between bicuspid and tricuspid patients (87.1% vs 79.5%, log-rank p=0.126). Multivariate Cox regression analysis adjusting for confounding factors revealed a similar risk of all-cause mortality in the BAV population (hazard ratio [HR] 0.86, 95% confidence interval [CI]: 0.44-1.70, p=0.666). Except for the rate of permanent pacemaker implantation that was lower in BAV patients (11.9% vs 21.9%, p=0.041), the incidence of other clinical adverse events was comparable between the two groups. Both BAV and TAV patients showed an obvious improvement in valve haemodynamics, which was sustained for three years. In addition, similar left ventricular reverse remodelling was found during follow-up. CONCLUSIONS BAV patients showed similar satisfactory three-year clinical outcomes, persistent valve haemodynamics improvement, and obvious cardiac reverse remodelling after TAVI compared to TAV patients.
Collapse
Affiliation(s)
- Dao Zhou
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Abuduwufuer Yidilisi
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Jiaqi Fan
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Yebei Zhang
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China,Department of Cardiology, People's Hospital of Anji, Anji County, Zhejiang, People's Republic of China
| | - Hanyi Dai
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Gangjie Zhu
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Yuchao Guo
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Yuxin He
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Qifeng Zhu
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Xinping Lin
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Huajun Li
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Jubo Jiang
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Stella Ng
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Cheng Li
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Kaida Ren
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Lihan Wang
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| | - Xianbao Liu
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Jiefang Road No.88, Hangzhou 310009, People’s Republic of China
| | - Jian’an Wang
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
| |
Collapse
|
8
|
Chen D, Zhang Y, Yidilisi A, Xu Y, Dong Q, Jiang J. Causal Associations Between Circulating Adipokines and Cardiovascular Disease: A Mendelian Randomization Study. J Clin Endocrinol Metab 2022; 107:e2572-e2580. [PMID: 35134201 PMCID: PMC9113792 DOI: 10.1210/clinem/dgac048] [Citation(s) in RCA: 19] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2021] [Indexed: 11/19/2022]
Abstract
CONTEXT Observational studies have suggested associations between adipokines and cardiovascular disease (CVD), but the roles of certain adipokines remain controversial, and these associations have not yet been ascertained causally. OBJECTIVE To investigate whether circulating adipokines causally affect the risk of CVD using 2-sample Mendelian randomization (MR). METHODS Independent genetic variants strongly associated with adiponectin, resistin, chemerin, and retinol binding protein 4 (RBP4) were selected from public genome-wide association studies. Summary-level statistics for CVD, including coronary artery disease (CAD), myocardial infarction, atrial fibrillation (AF), heart failure (HF), and stroke and its subtypes were collected. The inverse-variance weighted and Wald ratio methods were used for the MR estimates. The MR pleiotropy residual sum and outlier, weighted median, MR-Egger, leave-one-out analysis, MR Steiger, and colocalization analyses were used in the sensitivity analysis. RESULTS Genetically predicted resistin levels were positively associated with AF risk (odds ratio [OR] 1.09; 95% confidence interval [CI], 1.04-1.13; P = 4.1 × 10-5), which was attenuated to null after adjusting for blood pressure. We observed suggestive associations between higher genetically predicted chemerin levels and an increased risk of CAD (OR 1.27; 95% CI, 1.01-1.60; P = 0.040), higher genetically predicted RBP4 levels and an increased risk of HF (OR 1.14; 95% CI, 1.02-1.27; P = 0.024). There was no causal association between genetically predicted adiponectin levels and CVD risk. CONCLUSIONS Our findings reveal the causal association between resistin and AF, probably acting through blood pressure, and suggest potential causal associations between chemerin and CAD, RBP4, and HF.
Collapse
Affiliation(s)
- Delong Chen
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Yuxuan Zhang
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Abuduwufuer Yidilisi
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Yi Xu
- Department of Cardiology, Ningbo First Hospital, Ningbo, China
| | - Qichao Dong
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Jun Jiang
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| |
Collapse
|
9
|
Zhu Q, Yuan Z, Xu Y, Chen J, Ng S, Yidilisi A, Ren K, Chen Y, Hu W, Zhu G, Liu F, Dang M, He Y, Guo Y, Fan J, Liu X, Wang J. Validation of a novel staging classification system based on the extent of cardiac damage among Chinese patients after transcatheter aortic valve replacement: A single-center retrospective study. Catheter Cardiovasc Interv 2022; 99 Suppl 1:1482-1489. [PMID: 35324060 DOI: 10.1002/ccd.30147] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/04/2022] [Accepted: 02/21/2022] [Indexed: 12/28/2022]
Abstract
OBJECTIVES We aimed to validate a novel staging system for aortic stenosis (AS) in a Chinese patient cohort undergoing transcatheter aortic valve replacement (TAVR), and to compare this classification system to the traditional Society of Thoracic Surgeons (STS) score for TAVR risk stratification. BACKGROUND A novel staging system for AS based on the extent of cardiac damage upon echocardiography was recently proposed. METHODS Patients were prospectively enrolled into the Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population and analyzed retrospectively following additional exclusion criteria. On the basis of echocardiographic findings of cardiac damage, patients were classified into five stages (0-4). RESULTS A total of 427 patients were included in the current analysis. Forty-eight deaths occurred during a median follow-up of 730 days following TAVR. The staging system showed a statistically significant association between cardiac damage and all-cause mortality; advanced stages were associated with higher mortality. In a multivariate-adjusted Cox proportional hazards regression model, stage and STS scores served as risk factors for 2-year mortality. Each increment in the staging class was associated with an increased risk of mortality (hazard ratio, 1.275; 95% confidence interval [CI], 1.052-1.545). Receiver operating characteristic (ROC) curves were plotted for stage (area under the curve, 0.644; 95% CI, 0.562-0.725) and STS score (0.661; 0.573-0.749), and with no statistically significant differences between ROC curves (p = 0.920). CONCLUSIONS We validated a novel staging system as a key risk factor for 2-year mortality in a Chinese TAVR patient cohort. Efficacy for risk stratification was comparable to the STS score.
Collapse
Affiliation(s)
- Qifeng Zhu
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Zhengdu Yuan
- Department of Cardiology, Taizhou Municipal Hospital, Taizhou, China
| | - Yeming Xu
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- School of Medicine, Zhejiang University, Hangzhou, China
| | - Jun Chen
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- School of Medicine, Zhejiang University, Hangzhou, China
| | - Stella Ng
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- School of Medicine, Zhejiang University, Hangzhou, China
| | - Abuduwufuer Yidilisi
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- School of Medicine, Zhejiang University, Hangzhou, China
| | - Kaida Ren
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Yuwen Chen
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Wangxing Hu
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Gangjie Zhu
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Feng Liu
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- School of Medicine, Zhejiang University, Hangzhou, China
| | - Mengqiu Dang
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Yuxin He
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Yuchao Guo
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Jiaqi Fan
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Xianbao Liu
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Jian'an Wang
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| |
Collapse
|
10
|
Zhou D, Liu X, Chen J, Fan J, Yidilisi A, Dai H, Xu Y, Zhu G, Guo Y, Wang J. SELF-EXPANDING TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH EXTREMELY HORIZONTAL AORTA. J Am Coll Cardiol 2022. [DOI: 10.1016/s0735-1097(22)01781-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
11
|
Dai H, Zhou D, Yidilisi A, Liu X, Wang J. Self-Expanding Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation With Extremely Horizontal Aorta: A Case Series. J Invasive Cardiol 2022; 34:E257-E258. [PMID: 35235535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Transcatheter aortic valve replacement (TAVR) is not the preferred therapy for pure aortic regurgitation (AR). Extremely horizontal aorta (aorta root angle ≥70°) is regarded as an "off-label" use in self-expanding TAVR. This case series enrolled 7 consecutive pure AR patients who had extremely horizontal aorta and underwent self-expanding TAVR from the TORCH registry. To the best of our knowledge, this is the first study to report successful self-expanding TAVR for pure AR with extremely horizontal aorta, revealing the feasibility of both transapical and transfemoral TAVR in this challenging population.
Collapse
Affiliation(s)
| | | | | | - Xianbao Liu
- Department of Cardiology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou 310009, China.
| | | |
Collapse
|
12
|
Zhou D, Chen J, Fan J, Yidilisi A, Dai H, Xu Y, Zhu G, Guo Y, Wang J, Liu X. Self‐expanding transcatheter aortic valve replacement in patients with extremely horizontal aortas. Catheter Cardiovasc Interv 2022; 99 Suppl 1:1432-1439. [PMID: 35094487 DOI: 10.1002/ccd.30094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Accepted: 01/07/2022] [Indexed: 11/12/2022]
Affiliation(s)
- Dao Zhou
- Department of Cardiology Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
| | - Jun Chen
- Department of Cardiology Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
| | - Jiaqi Fan
- Department of Cardiology Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
| | - Abuduwufuer Yidilisi
- Department of Cardiology Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
| | - Hanyi Dai
- Department of Cardiology Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
| | - Yeming Xu
- Department of Cardiology Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
| | - Gangjie Zhu
- Department of Cardiology Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
| | - Yuchao Guo
- Department of Cardiology Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
| | - Jian'an Wang
- Department of Cardiology Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
| | - Xianbao Liu
- Department of Cardiology Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China
| |
Collapse
|